| INMODE LTD IS -,01 |
| Israel |
| Gesundheit |
| IL0011595993 / A2PP3A |
| 154 (Frankfurt) / INMD (NASDAQ) |
| FRA:154, ETR:154, 154:GR, NASDAQ:INMD |
| - |
| https://www.inmodemd.com/ |
|
InMode Ltd. is a medical technology company that develops, manufactures, and markets minimally invasive and non-invasive aesthetic treatment systems. Its current product portfolio is built around radio frequency-based platforms used in body and face ..
>Volltext.. |
| 741.84 Mio. EUR |
| 306.57 Mio. EUR |
| 324.7 Mio. EUR |
| 60.57 Mio. EUR |
| 67.18 Mio. EUR |
| 1.08 EUR |
| 3.86 Mio. EUR |
| 343.38 Mio. EUR |
| 77.59 Mio. EUR |
| 6.31 |
| -3.77% |
| -55.26% |
| - |
| - |
| - |
| - |
| INMODE |
| 16.09.26 |
|
||||
|
||||
|